强制性处方限制与骨科手术后阿片类药物使用情况
该研究比较了州级强制性阿片类药物处方限制法律实施前后两组接受6种常见骨科手术的患者,发现立法后初始处方药片数量、总吗啡毫克当量及30天和30至90天累积MME均显著下降,且术前阿片耐受患者术后长期使用阿片类药物的风险显著高于术前未使用阿片类药物的患者。
要点
- 立法后初始处方药片数由49.65片降至22.08片,总MME由417.67降至173.86(均p<0.001)。
- 立法后30天累积MME由790.01降至524.61(p<0.001),30至90天MME由243.51降至208.54(p=0.008)。
- 术前阿片耐受者术后长期使用阿片类药物的比值比为8.73(95%CI 6.21至12.29)。
核心结论
- 州级强制性阿片类药物处方限制实施后,骨科手术后阿片类药物使用量出现具有临床意义且显著的下降。
研究设计与样本
- 比较法律实施前(836例)与实施后(940例)两个患者队列,纳入接受6种常见骨科手术的阿片耐受及阿片未耐受患者,排除同一次手术中接受超过1个主要手术的患者。
主要发现
- 立法后所有患者的初始处方药片数量为49.65片(立法前)对22.08片(立法后)(p<0.001),总MME为417.67(立法前)对173.86(立法后)(p<0.001),无论患者术前阿片暴露情况如何(均p<0.001)。
- 立法后平均累积30天MME为790.01(立法前)对524.61(立法后)(p<0.001),30至90天MME为243.51(立法前)对208.54(立法后)(p=0.008)。
- 尽管被立法明确豁免,阿片耐受患者的累积30天MME也出现显著下降,为1,304.08(立法前)对1,015.19(立法后)(p=0.0016)。
- 阿片耐受患者在术后所有时间点需要更多阿片类药物,且与术前阿片未耐受者相比长期使用阿片类药物的可能性增加(比值比8.73,95%置信区间6.21至12.29)。
关键数值与推荐
- 立法后初始处方药片数量为22.08片,立法前为49.65片(p<0.001)。
- 立法后总MME为173.86,立法前为417.67(p<0.001)。
- 立法后30天累积MME为524.61,立法前为790.01(p<0.001)。
- 立法后30至90天MME为208.54,立法前为243.51(p=0.008)。
- 阿片耐受患者立法后累积30天MME为1,015.19,立法前为1,304.08(p=0.0016)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Since 2016, over half of the states in the United States have passed mandatory limits on opioid prescriptions, with limited evidence of effectiveness. In this study, we evaluated postoperative opioid prescriptions following orthopaedic surgery before and after the implementation of one of the earliest such laws. METHODS: Following the implementation of state legislation limiting opioid prescriptions for opioid-naïve patients, 2 patient cohorts (pre-law and post-law) were compared. Both opioid-tolerant and opioid-naïve patients undergoing 6 common orthopaedic procedures (total knee arthroplasty, rotator cuff repair, anterior cruciate ligament reconstruction, open reduction and internal fixation for a distal radial fracture, open reduction and internal fixation for an ankle fracture, and lumbar discectomy) met inclusion criteria. Patients undergoing >1 primary procedure in the same operative session were excluded. All benzodiazepine and opioid prescriptions from 30 days before to 90 days after the surgical procedure were recorded. Logistic regression was performed to determine risk factors for prolonged postoperative opioid use. RESULTS: In this study, 836 pre-law patients were compared with 940 post-law patients. The 2 groups were similar with regard to demographic variables, baseline opioid tolerance, and recent benzodiazepine use (all p > 0.05). Post-law, for all patients, there were decreases in the initial prescription pill quantity (49.65 pills pre-law and 22.08 pills post-law; p < 0.001) and the total morphine milligram equivalents (MMEs) (417.67 MMEs pre-law and 173.86 MMEs post-law; p < 0.001), regardless of patient preoperative opioid exposure (all p < 0.001). Additionally, there were decreases in the mean cumulative 30-day MMEs (790.01 MMEs pre-law and 524.61 MMEs post-law; p < 0.001) and the 30 to 90-day MMEs (243.51 MMEs pre-law and 208.54 MMEs post-law; p = 0.008). Despite being specifically exempted from the legislation, opioid-tolerant patients likewise experienced a significant decrease in cumulative 30-day MMEs (1,304.08 MMEs pre-law and 1,015.19 MMEs post-law; p = 0.0016). Opioid-tolerant patients required more postoperative opioids at all time points and had an increased likelihood of prolonged opioid use compared with those who were opioid-naïve preoperatively (odds ratio, 8.73 [95% confidence interval, 6.21 to 12.29]). CONCLUSIONS: A clinically important and significant reduction in opioid utilization after orthopaedic surgery was observed following the implementation of statewide mandatory opioid prescription limits. CLINICAL RELEVANCE: After implementation of mandatory opioid prescription regulations, a clinically important and significant decline in the volume of opioids dispensed in the short term and intermediate term following orthopaedic surgery was observed. Furthermore, important clinical predictors of prolonged postoperative opioid use, including preoperative opioid use and preoperative benzodiazepine use, were identified. These findings have important implications for public health, as well as the potential to influence policymakers and to change practice among orthopaedic surgeons.
引用
- Reid DBC, Shah KN, Shapiro BH, et al. Mandatory Prescription Limits and Opioid Utilization Following Orthopaedic Surgery. J Bone Joint Surg Am. 2019. PMID: 31094987. doi:10.2106/JBJS.18.00943
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。